Overview
Alomone Labs is pleased to offer the Opioid Receptor Antibody Explorer Kit (#AK-520). The Explorer Kit contains opioid receptor antibodies, ideal for screening purposes.
Compounds
Product Name | Cat # | Size |
---|---|---|
Anti-Nociceptin Receptor (OPRL1) Antibody |
AOR-015 | 1 x 50 µl |
Nociceptin Receptor/OPRL1 Blocking Peptide |
BLP-OR015 | 1 x 40 µg |
Anti-δ-Opioid Receptor (OPRD1) (extracellular) Antibody |
AOR-014 | 1 x 50 µl |
δ-Opioid Receptor/OPRD1 (extracellular) Blocking Peptide |
BLP-OR014 | 1 x 40 µg |
Anti-κ-Opioid Receptor (OPRK1) (extracellular) Antibody |
AOR-012 | 1 x 50 µl |
κ-Opioid Receptor/OPRK1 (extracellular) Blocking Peptide |
BLP-OR012 | 1 x 40 µg |
Anti-µ-Opioid Receptor (OPRM1) (extracellular) Antibody |
AOR-011 | 1 x 50 µl |
µ-Opioid Receptor/OPRM1 (extracellular) Blocking Peptide |
BLP-OR011 | 1 x 40 µg |
Scientific Background
Endogenous opiates such as endorphins, endomorphins, and enkephalins, as well as opiate drugs (including morphine) exert their effects by binding to opioid receptors. Three "classic" types of opioid receptors have been identified: mu (µ)-opioid (MOP) receptor, delta (δ)-opioid (DOP) receptor, and kappa (κ)-opioid (KOP) receptor.1 Recently, the nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor was also described. Despite its significant sequence homology, its pharmacological profile differs greatly from those of the classic µ, δ, and κ receptors.2
The opioid receptors belong to the G protein-coupled receptor (GPCR) superfamily whose members share a common structure of seven putative transmembrane domains, an extracellular amino terminus, a cytoplasmic carboxyl terminus, and a third intracellular loop important for binding G proteins.1
All three classic opioid receptors mediate opioid-induced analgesia. Supraspinal analgesia is mainly mediated by the µ-opioid receptor, whereas µ-, δ-, and κ-receptors participate in the control of pain at the spinal level.3 The opioid receptors also mediate the mood-altering properties of opioids.4 Cross-talk between µ- and δ- opioid receptors was demonstrated when subeffective doses of d-opioid receptors agonists modulated m-mediated analgesia.5
- Pan, L. et al. (2005) Neuroscience 133, 209.
- http://www.iuphar-db.org/DATABASE/FamilyIntroductionForward?familyId=50.
- Matthes, H.W. et al. (1998) J. Neurosci. 18, 7285.
- Di Chiara, G. and North, R.A. (1992) Trends Pharmacol. Sci. 13, 185.
- Vaught, J.L. et al. (1982) Life Sci. 30, 1443.
Related Products
Need Help With This Product?
Our reagent specialists are here to help you find the best product for your application. Please call or email us and we will be happy to help you find the right product for the job.
Call us at
+972 2587 2202 or Email Us